chr14-50118856-C-CAA

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_006939.4(SOS2):​c.3490-4_3490-3insTT variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0512 in 1,134,490 control chromosomes in the GnomAD database, including 378 homozygotes. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 82 hom., cov: 0)
Exomes 𝑓: 0.054 ( 296 hom. )

Consequence

SOS2
NM_006939.4 splice_region, splice_polypyrimidine_tract, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 2.39
Variant links:
Genes affected
SOS2 (HGNC:11188): (SOS Ras/Rho guanine nucleotide exchange factor 2) This gene encodes a regulatory protein that is involved in the positive regulation of ras proteins. Mutations in this gene are associated with Noonan Syndrome-9. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP6
Variant 14-50118856-C-CAA is Benign according to our data. Variant chr14-50118856-C-CAA is described in ClinVar as [Benign]. Clinvar id is 475752.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0597 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SOS2NM_006939.4 linkuse as main transcriptc.3490-4_3490-3insTT splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000216373.10 NP_008870.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SOS2ENST00000216373.10 linkuse as main transcriptc.3490-4_3490-3insTT splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_006939.4 ENSP00000216373 P1Q07890-1
SOS2ENST00000543680.5 linkuse as main transcriptc.3391-4_3391-3insTT splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 ENSP00000445328 Q07890-2

Frequencies

GnomAD3 genomes
AF:
0.0303
AC:
4322
AN:
142640
Hom.:
82
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00712
Gnomad AMI
AF:
0.0899
Gnomad AMR
AF:
0.0321
Gnomad ASJ
AF:
0.0209
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00822
Gnomad FIN
AF:
0.0463
Gnomad MID
AF:
0.0323
Gnomad NFE
AF:
0.0443
Gnomad OTH
AF:
0.0337
GnomAD3 exomes
AF:
0.0382
AC:
3970
AN:
103896
Hom.:
41
AF XY:
0.0403
AC XY:
2289
AN XY:
56850
show subpopulations
Gnomad AFR exome
AF:
0.0103
Gnomad AMR exome
AF:
0.0242
Gnomad ASJ exome
AF:
0.0330
Gnomad EAS exome
AF:
0.00559
Gnomad SAS exome
AF:
0.0157
Gnomad FIN exome
AF:
0.0498
Gnomad NFE exome
AF:
0.0505
Gnomad OTH exome
AF:
0.0377
GnomAD4 exome
AF:
0.0542
AC:
53736
AN:
991764
Hom.:
296
Cov.:
24
AF XY:
0.0539
AC XY:
25812
AN XY:
478790
show subpopulations
Gnomad4 AFR exome
AF:
0.0122
Gnomad4 AMR exome
AF:
0.0290
Gnomad4 ASJ exome
AF:
0.0364
Gnomad4 EAS exome
AF:
0.00447
Gnomad4 SAS exome
AF:
0.0220
Gnomad4 FIN exome
AF:
0.0482
Gnomad4 NFE exome
AF:
0.0602
Gnomad4 OTH exome
AF:
0.0455
GnomAD4 genome
AF:
0.0303
AC:
4318
AN:
142726
Hom.:
82
Cov.:
0
AF XY:
0.0302
AC XY:
2083
AN XY:
68992
show subpopulations
Gnomad4 AFR
AF:
0.00711
Gnomad4 AMR
AF:
0.0321
Gnomad4 ASJ
AF:
0.0209
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00801
Gnomad4 FIN
AF:
0.0463
Gnomad4 NFE
AF:
0.0443
Gnomad4 OTH
AF:
0.0334

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Noonan syndrome 9 Benign:3
Benign, criteria provided, single submitterclinical testingGenome-Nilou Lab-- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 19, 2019Variant summary: SOS2 c.3490-5_3490-4dupTT alters a nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.038 in 103896 control chromosomes in the gnomAD database (exomes dataset), including 41 homozygotes. The observed variant frequency is approximately 15000 fold of the estimated maximal expected allele frequency for a pathogenic variant in SOS2 causing Noonan Syndrome and Related Conditions phenotype (2.5e-06), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.3490-5_3490-4dupTT in individuals affected with Noonan Syndrome and Related Conditions and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submissions from other clinical diagnostic laboratories (evaluation after 2014) cited the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, criteria provided, single submitterclinical testingGeneDxNov 01, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
SOS2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 06, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Noonan syndrome and Noonan-related syndrome Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJul 08, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10658395; hg19: chr14-50585574; API